Courage Kenny Rehabilitation Institutes Trp in Golden Valley, MN

Courage Kenny Rehabilitation Institutes Trp is a medicare and medicaid certified nursing home in Golden Valley, Minnesota. It is located in Hennepin county at 3915 Golden Valley Road, Golden Valley, Minnesota 55422. You can reach out to the office of Courage Kenny Rehabilitation Institutes Trp via phone at (612) 775-2835. This skilled nursing facility has 56 federally certified beds with average occupancy rate of 62.86%. Its legal business name is Allina Health System and has the following ownership type - Non Profit - Corporation.

Courage Kenny Rehabilitation Institutes Trp (Medicare CCN 245519) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1988 (36 years certified) and the last quality survey was conducted in February, 2020.

Contact Information

Courage Kenny Rehabilitation Institutes Trp
3915 Golden Valley Road, Golden Valley, Minnesota 55422
(612) 775-2835


Nursing Home Profile

NameCourage Kenny Rehabilitation Institutes Trp
Location3915 Golden Valley Road, Golden Valley, Minnesota
Certified ByMedicare and Medicaid
No. of Certified Beds56
Occupancy Rate62.86%
Medicare ID (CCN)245519
Legal Business NameAllina Health System
Ownership TypeNon Profit - Corporation

NPI Associated with this Nursing Home:

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Courage Kenny Rehabilitation Institutes Trp from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1245579713
Organization NameALLINA HEALTH SYSTEM
Doing Business AsCOURAGE KENNY REHABILITATION INSTITUTE'S TRANSITIONAL REHAB PROGRAM
Address3915 Golden Valley Rd, Golden Valley, MN 55422
Phone Number763-520-0811

News Archive

Fats in our stomach may reduce the protective effects of antioxidants

Scientists at the University of Glasgow found that in the presence of lipid the ability of antioxidants, such as ascorbic acid (the active component of vitamin C), to protect against the generation of potential cancer-forming compounds in the stomach is less than when no lipids are present.

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes in CLL/SLL patients

Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.

Many migrant farmworkers have visual impairment but do not receive routine vision screening

Migrant farmworkers have substantial rates of near- and distant-vision problems, but three-fourths have never had a vision screening test, reports a study in the October issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.

Children's ball pits full of pathogenic microbes

A new study has found that the ball pits used by children in physical therapy clinics may be colonized with various microorganisms, some of which are pathogenic.

Read more Medical News

› Verified 4 days ago


NPI Number1699700369
Organization NameCOURAGE RESIDENCE
Address3915 Golden Valley Rd, Golden Valley, MN 55422
Phone Number763-520-0811

News Archive

Fats in our stomach may reduce the protective effects of antioxidants

Scientists at the University of Glasgow found that in the presence of lipid the ability of antioxidants, such as ascorbic acid (the active component of vitamin C), to protect against the generation of potential cancer-forming compounds in the stomach is less than when no lipids are present.

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes in CLL/SLL patients

Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.

Many migrant farmworkers have visual impairment but do not receive routine vision screening

Migrant farmworkers have substantial rates of near- and distant-vision problems, but three-fourths have never had a vision screening test, reports a study in the October issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.

Children's ball pits full of pathogenic microbes

A new study has found that the ball pits used by children in physical therapy clinics may be colonized with various microorganisms, some of which are pathogenic.

Read more Medical News

› Verified 4 days ago

Quality Ratings:

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Courage Kenny Rehabilitation Institutes Trp are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Courage Kenny Rehabilitation Institutes Trp give to their patients.
Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Fats in our stomach may reduce the protective effects of antioxidants

Scientists at the University of Glasgow found that in the presence of lipid the ability of antioxidants, such as ascorbic acid (the active component of vitamin C), to protect against the generation of potential cancer-forming compounds in the stomach is less than when no lipids are present.

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes in CLL/SLL patients

Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.

Many migrant farmworkers have visual impairment but do not receive routine vision screening

Migrant farmworkers have substantial rates of near- and distant-vision problems, but three-fourths have never had a vision screening test, reports a study in the October issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.

Children's ball pits full of pathogenic microbes

A new study has found that the ball pits used by children in physical therapy clinics may be colonized with various microorganisms, some of which are pathogenic.

Read more Medical News

› Verified 4 days ago

Complaints, Fines and Penalties:

Number of Facility Reported Incidents0
Number of Substantiated Complaints0
Number of Fines0
Total Amount of Fines in Dollars$0
Number of Payment Denials0
Total Number of Penalties0

Patients' Stay Experience:

The resident survey data of Courage Kenny Rehabilitation Institutes Trp is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percentage of long-stay residents whose need for help with daily activities has increased014.46
Percentage of long-stay residents who lose too much weight05.51